{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:54:09Z","timestamp":1789055649932,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008126","name":"Jeju National University Hospital","doi-asserted-by":"publisher","award":["2019-01"],"award-info":[{"award-number":["2019-01"]}],"id":[{"id":"10.13039\/501100008126","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.kint.2024.10.022","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T20:56:38Z","timestamp":1731704198000},"page":"521-529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Post-hoc analysis of the CARES trial suggests delayed progression of chronic kidney disease in patients with gout during urate-lowering therapy"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7284-4964","authenticated-orcid":false,"given":"Byeongzu","family":"Ghang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jino","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Sung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Seo","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunwoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.L.","family":"Liew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinseok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duk-Hee","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2024.10.022_bib1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fmed.2018.00160","article-title":"Physiology of hyperuricemia and urate-lowering treatments","volume":"5","author":"Benn","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.kint.2024.10.022_bib2","first-page":"161","article-title":"Prevalence of chronic kidney disease and associated risk factors\u2014United States, 1999-2004","volume":"56","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.kint.2024.10.022_bib3","article-title":"Hyperuricemia is an independent risk factor for new onset micro-albuminuria in a middle-aged and elderly population: a prospective cohort study in Taiwan","volume":"8","author":"Chang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2024.10.022_bib4","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/hr.2013.11","article-title":"Changes in serum uric acid have a reciprocal effect on eGFR change: a 10-year follow-up study of community-based screening in Okinawa, Japan","volume":"36","author":"Iseki","year":"2013","journal-title":"Hypertens Res"},{"key":"10.1016\/j.kint.2024.10.022_bib5","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41581-019-0174-z","article-title":"The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD","volume":"15","author":"Sato","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2024.10.022_bib6","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1097\/01.ASN.0000034910.58454.FD","article-title":"A\u00a0role for uric acid in the progression of renal disease","volume":"13","author":"Kang","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.10.022_bib7","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1093\/ndt\/gft029","article-title":"Uric acid and chronic kidney disease: which is chasing which?","volume":"28","author":"Johnson","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.10.022_bib8","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMoa1915833","article-title":"Effects of allopurinol on the progression of chronic kidney disease","volume":"382","author":"Badve","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2024.10.022_bib9","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1056\/NEJMoa1916624","article-title":"Serum urate lowering with allopurinol and kidney function in type 1 diabetes","volume":"382","author":"Doria","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2024.10.022_bib10","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1053\/j.ajkd.2018.06.028","article-title":"Febuxostat therapy for patients with stage 3 CKD and asymptomatic hyperuricemia: a randomized trial","volume":"72","author":"Kimura","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.10.022_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210487","article-title":"Prevalence and treatment of gout among patients with chronic kidney disease in the Irish health system: a national study","volume":"14","author":"Mohammed","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2024.10.022_bib12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/ndt\/gfu352","article-title":"Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease: the German Chronic Kidney Disease (GCKD) study","volume":"30","author":"Jing","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.10.022_bib13","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1681\/ASN.2020040523","article-title":"Only hyperuricemia with crystalluria, but not asymptomatic hyperuricemia, drives progression of chronic kidney disease","volume":"31","author":"Sellmayr","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.10.022_bib14","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa1710895","article-title":"Cardiovascular safety of febuxostat or allopurinol in patients with gout","volume":"378","author":"White","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2024.10.022_bib15","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/acr.24180","article-title":"2020 American College of Rheumatology Guideline for the Management of Gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.kint.2024.10.022_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2024.10.022_bib17","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1532-5415.1985.tb07117.x","article-title":"Longitudinal studies on the rate of decline in renal function with age","volume":"33","author":"Lindeman","year":"1985","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.kint.2024.10.022_bib18","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1172\/JCI102286","article-title":"Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males","volume":"29","author":"Davies","year":"1950","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2024.10.022_bib19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/bdd.1988","article-title":"Kidney function changes with aging in adults: comparison between cross-sectional and longitudinal data analyses in renal function assessment","volume":"36","author":"Chung","year":"2015","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.kint.2024.10.022_bib20","first-page":"232","article-title":"Kidney function tests in aged males","volume":"1","author":"Shock","year":"1946","journal-title":"Geriatrics"},{"key":"10.1016\/j.kint.2024.10.022_bib21","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMra054415","article-title":"Assessing kidney function\u2014measured and estimated glomerular filtration rate","volume":"354","author":"Stevens","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2024.10.022_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005308","article-title":"Prevalence of birefringent crystals in cardiac and prostatic tissues, an observational study","volume":"4","author":"Park","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.kint.2024.10.022_bib23","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/jamacardio.2019.3201","article-title":"Dual-energy computed tomography detection of cardiovascular monosodium urate deposits in patients with gout","volume":"4","author":"Klauser","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.kint.2024.10.022_bib24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.rdc.2017.04.004","article-title":"Genomic influences on hyperuricemia and gout","volume":"43","author":"Merriman","year":"2017","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.kint.2024.10.022_bib25","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1136\/annrheumdis-2019-215521","article-title":"Genome-wide association study revealed novel loci which aggravate asymptomatic hyperuricaemia into gout","volume":"78","author":"Kawamura","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2024.10.022_bib26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1161\/HYPERTENSIONAHA.116.08240","article-title":"Activation of renal (pro)renin receptor contributes to high fructose-induced salt sensitivity","volume":"69","author":"Xu","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2024.10.022_bib27","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/HJH.0b013e328303205d","article-title":"Oxonic acid-induced hyperuricemia elevates plasma aldosterone in experimental renal insufficiency","volume":"26","author":"Er\u00e4ranta","year":"2008","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.kint.2024.10.022_bib28","doi-asserted-by":"crossref","first-page":"F991","DOI":"10.1152\/ajprenal.00283.2001","article-title":"Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism","volume":"282","author":"Mazzali","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2024.10.022_bib29","doi-asserted-by":"crossref","first-page":"F471","DOI":"10.1152\/ajprenal.00560.2012","article-title":"Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease","volume":"304","author":"Ryu","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2024.10.022_bib30","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1159\/000345509","article-title":"Uric acid-induced endothelial dysfunction is associated with mitochondrial alterations and decreased intracellular ATP concentrations","volume":"121","author":"S\u00e1nchez-Lozada","year":"2012","journal-title":"Nephron Exp Nephrol"},{"key":"10.1016\/j.kint.2024.10.022_bib31","doi-asserted-by":"crossref","first-page":"40732","DOI":"10.1074\/jbc.M112.399899","article-title":"Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver","volume":"287","author":"Lanaspa","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2024.10.022_bib32","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1164\/rccm.200808-1274OC","article-title":"Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis","volume":"179","author":"Gasse","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.kint.2024.10.022_bib33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.kint.2024.10.022_bib34","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1053\/j.ajkd.2016.11.006","article-title":"AJKD Atlas of Renal Pathology: Gouty Nephropathy","volume":"69","author":"Lusco","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.10.022_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jmii.2017.12.004","article-title":"Monosodium urate crystals induced ICAM-1 expression and cell-cell adhesion in renal mesangial cells: implications for the pathogenesis of gouty nephropathy","volume":"53","author":"Luo","year":"2020","journal-title":"J\u00a0Microbiol Immunol Infect"},{"key":"10.1016\/j.kint.2024.10.022_bib36","doi-asserted-by":"crossref","first-page":"F786","DOI":"10.1152\/ajprenal.00083.2013","article-title":"Urate-induced acute renal failure and chronic inflammation in liver-specific Glut9 knockout mice","volume":"305","author":"Preitner","year":"2013","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253824007890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253824007890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T04:40:17Z","timestamp":1762231217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253824007890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0085253824007890"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2024.10.022","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-hoc analysis of the CARES trial suggests delayed progression of chronic kidney disease in patients with gout during urate-lowering therapy","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2024.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2024.11.025","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society of Nephrology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}